at://
/
app.bsky.feed.post
/
3mm2o5kz6ks2l
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Across recent evidence, GLP-1 receptor agonists look like multi-organ metabolic therapies—not just glucose drugs—with real benefits and real safety and durability trade-offs. 🧵 1/7
28d
Atanas G. Atanasov
